20184 ⎘
Medicinal preparations characterised by special physical form; Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug; Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches; Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
Adhesive-forming composition and blend of adhesives obtained therefrom
#302Crystallization inhibition of drugs in transdermal drug delivery systems and methods of use
#303Transdermal therapeutic system for treating Parkinsonism
#304Transdermal methods and systems for treating Alzheimer's disease
#305Transdermal therapeutic system comprising an adhesive layer method for siliconizing the back layer or the system and use of said back layer
#306TRANSDERMAL DOSAGE FORM COMPRISING AN ACTIVE AGENT AND A SALT AND A FREE-BASE FORM OF AN ADVERSE AGENT
#307Compositions and method for treatment of Attention Deficit Disorder and Attention Deficit/Hyperactivity Disorder with methylphenidate
#308Polymeric Film
#309Water-dispersible patch containing an active agent for dermal delivery
#310FENTANYL SUSPENSION-BASED SILICONE ADHESIVE FORMULATIONS AND DEVICES FOR TRANSDERMAL DELIVERY OF FENTANYL
#311Use of film-forming hair care polymers from the group of polyurethanes and pharmaceutical preparations and patches that contain these polymers
#312Preparation for Topical Application and Methods of Delivering an Active Agent to a Substrate
#313Compositions and methods for delivery of amino-functional drugs
#314Method for providing an active agent topically to the skin
#315Method of making silicone pressure sensitive adhesives for delivering hydrophilic drugs
#316Fentanyl suspension-based silicone adhesive formulations and devices for transdermal delivery of fentanyl
#317PREPARATIONS FOR TOPICAL SKIN USE AND TREATMENT
#318Formulations and Methods for Enhancing the Transdermal Penetration of a Drug
#319Compositions and method for treatment of attention deficit disorder and attention deficit/hyperactivity disorder with methylphenidate
#320Transdermal therapeutic system for Parkinson's Disease
#321Low-concentration capsaicin patch and methods for treating neuropathic pain
#322Fentanyl suspension-based silicone adhesive formulations and devices for transdermal delivery of fentanyl
#323Transdermal pharmaceutical preparation with a progesterone A-specific ligand (PRASL) as active ingredient
#324Transdermal drug delivery device including an occlusive backing
#325Transdermal delivery of drugs based on crystal size
#326Device for transdermal administration of drugs including acrylic polymers
#327Transdermal therapeutic system suitable for heat application for promoting the permeation of active substances, and the use thereof
#328Transdermal patches having a siliconic adhesive matrix stabilized with methacrylic copolymers
#329Adhesive patch
#330Hot melt TTS for administering rotigotine
#331Packaging system for transdermal drug delivery systems
#332Device for the transdermal administration of a rotigotine base
#333Compositions and methods for controlling drug loss and delivery in transdermal drug delivery systems
#334Packaging meterials for transdermal drug delivery systems
#335Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces
#336Transdermal administration of ace inhibitors
#337Self-adhesive matrix plaster containing an active ingredient and based on polyurethane gels
#338Transdermal delivery system for the administration of rotigotine
#339Transdermal drug delivery devices comprising a polyurethane drug reservoir
#340Transdermal delivery system for alkaloids of aconitum species
#341Plaster having laminated support
#342Method for producing a transdermal therapeutic system which contains a D2 agonist
#343Terazosin transdermal device & methods
#344Composition and method for controlling drug delivery from silicone adhesive blends
#345Oral patch for treating mouth ulcers
#346Transfersome-containing transdermal film formulations and methods of use
#347Microreservoir system based on polysiloxanes and ambiphilic solvents
#348Drug formulations having reduced abuse potential
#349Loratadine transdermal device and methods